• Thursday, Oct 01, 2020
  • Last Update : 09:22 pm

Beximco submits Remdesivir sample to DGDA before Eskayef

  • Published at 07:52 pm May 9th, 2020
Remdesivir
Reuters

The drug has grabbed attention as one of the most promising treatments for Covid-19

Beximco Pharmaceuticals has said it has submitted final product samples of its Remdesivir to the drug administration on May 7.

In a statement sent to the media on Saturday, the drug manufacturer referred to reports ran by several outlets on Friday which said that Eskayef Pharmaceuticals was the first Bangladeshi company to produce the drug used to treat coronavirus patients.

“We would like to clarify that Beximco Pharma not only was the first company in Bangladesh to produce this drug but also the only company which has submitted final product samples to drug regulatory authority, Directorate General of Drug Administration (DGDA), for testing and approval. After producing this generic drug and successfully conducting all necessary tests in house, we submitted final product samples to DGDA on 7th May 2020 for testing and approval,” it reads.

The DGDA said that Eskayef submitted samples of its Remdesivir on Saturday.

“Beximco sent their samples on Wednesday and Eskayef today, though they were supposed to submit it yesterday,” said Ruhul Amin, a director with the DGDA.

Tests and chemical analysis of Beximco’s sample have already begun, he said before adding, “The analysis on Eskayef samples may start today or tomorrow.”

In its statement, Beximco said they had decided not to make an announcement over Remdesivir before getting the drug administration’s nod.

“Beximco Pharma refrained from announcing that it has produced the drug because it felt doing so without being validated by the regulatory body would have been irresponsible and unethical and would have mislead the public,” the company said in the statement.

Apart from Beximco and Eksayef, four other Bangladeshi drug manufacturers received the DGDA’s approval to produced Remdesivir.

They are, Beacon Pharmaceuticals, Incepta Pharmaceuticals, Health Care Pharmaceuticals and Square Pharmaceuticals.

Remdesivir, a drug developed by Gilead Sciences in the US, has grabbed attention as one of the most promising treatments for Covid-19, the respiratory disease caused by the novel coronavirus that has killed more than 250,000 people

252
251
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail